CMS seeks comment on PQRI medication measures
The Centers for Medicare & Medicaid Services (CMS) has contracted with Quality Insights of Pennsylvania to develop and maintain quality measures for the Physician Quality Reporting Initiative (PQRI). PQRI Measure 130, Documentation & Verification of Current Medications in the Medical Record, has been referred for further action in an effort to remove National Quality Forum time-limited endorsement status of the measure.
To date, CMS and Quality Insights of Pennsylvania have convened a Technical Expert Panel (TEP) and revised the measure based on an environmental scan, measure beta testing, and TEP recommendations.
CMS now is requesting stakeholder review and public comment on the measure, which must be received by July 30. Comments must be forwarded to Quality Insights of Pennsylvania via email. Commenters must include their name, credentials, and email address in the message, and indicate whether they’re commenting as an individual or as a representative on behalf of an organization.
To review the measure in more detail, visit CMS’ Measures Management System here.
A summary of all the comments received will be posted on the Measures Management System website about four weeks after the public comment period closes.
To date, CMS and Quality Insights of Pennsylvania have convened a Technical Expert Panel (TEP) and revised the measure based on an environmental scan, measure beta testing, and TEP recommendations.
CMS now is requesting stakeholder review and public comment on the measure, which must be received by July 30. Comments must be forwarded to Quality Insights of Pennsylvania via email. Commenters must include their name, credentials, and email address in the message, and indicate whether they’re commenting as an individual or as a representative on behalf of an organization.
To review the measure in more detail, visit CMS’ Measures Management System here.
A summary of all the comments received will be posted on the Measures Management System website about four weeks after the public comment period closes.